Plasma concentrations of high-mobility group box protein 1, soluble receptor for advanced glycation end-products and circulating DNA in patients with acute pancreatitis

Pancreatology

Volumn 9, Issue 4, 2009, Pages 383-391

  Kocsis, A K ^a   Szabolcs, A ^a   Hofner, P ^a   Takacs T ^a   Farkas, G ^a   Boda, K ^a   Mandi Y ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Acute pancreatitis, severe, mild; High mobility group box protein 1; Plasma DNA; Receptor for advanced glycation end products, soluble; Sepsis

Indexed keywords

CELL MARKER; DNA; HIGH MOBILITY GROUP B1 PROTEIN;

ACUTE PANCREATITIS; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOBIN GENE; GLYCATION; HUMAN; INFLAMMATORY CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEPSIS;

EID: 65649103076     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000181172     Document Type: Article

References (32)

1. Lotze MT, Tracey KJ: High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005; 5: 331-342.
2. Dimitriu IE, Baruah P, Manfredi AA, Bian-chi ME, Rovere-Querini P: HMGB1: guiding immunity from within. Trends Immunol 2005; 26:381-387.
3. Harris HE, Andersson U: The nuclear protein HMGB1 as a proinflammatory mediator. Eur J Immunol 2004; 34: 1503-1512.
4. Andersson U, Wang H, Palmblad K, Ave-berger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ: High mobility group 1 protein (HMG-1) stimulates proinflammatory cyto-kine synthesis in human monocytes. J Exp Med 2000; 192:565-570.
5. Wang H, Vishnibhakat BA, Bloom O, Zhang M, Ombrellino M, Sama A, Tracey KJ: Pro-inflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999; 126: 389-392.
6. Scaffidi P, Misteli T, Bianchi ME: Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418: 191-195.
7. Yamada S, Maruyama I: HMGB1, a novel inflammatory cytokine. Clin Chim Acta 2007; 375: 36-42.
8. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ: HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251.
9. Sundén-Cullnerg J, Norrby-Teglund A, Rouhiainen A, Rauvala H, Herman G, Tra-cey KJ, Lee ML, Andersson J, Tokics L, Treutiger CJ: Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock. Crit Care Med 2005; 33: 564-573.
10. Sundén-Cullberg J, Norrby-Teglund A, Treutiger CJ: The role of high mobility group box-1 protein in severe sepsis. Curr Opin Infect Dis 2006; 19:231-236.
11. Kokkola R, Andersson A, Mullins G, Ost-berg T, Treutiger CJ, Arnold B, Nawroth P, Andersen U, Harris HE: RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol 2005; 61: 1-9.
12. Bierhaus A, Humpert PM, Mrcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP: Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 2005; 83: 876-886.
13. Rauvala H, Rouhiainen A: RAGE as a receptor of HMGB1 (amphoterin): roles in health and disease. Curr Mol Med 2007; 7: 725-734.
14. Bopp C, Hofer S, Weitz J, Bierhaus A, Nawroth PP, Martin E, Büchler MW, Weigand MA: sRAGE is elevated in septic patients and associated with patients outcome. J Surg Res 2008; 147: 79-83.
15. Norman J: Role of cytokines in pathogenesis of acute pancreatitis. Am J Surg 1998; 175: 76 -83.
16. Makhija R, Kingsnorth AN: Cytokine storm in acute pancreatitis. J Hepatobiliary Pan-creat Surg 2002; 9: 401-410.
17. Beger HG, Rau BM: Severe acute pancreatitis: clinical course and management. World J Gastroenterol 2007; 13:5043-5051.
18. Formela LJ, Galloway SW, Kingsnorth AN: Inflammatory mediators in acute pancreatitis. Br J Surg 1995; 82: 6-13.
19. Zeerleder S: The struggle to detect circulating DNA. Crit Care 2006; 10: 14 2 .
20. Rhodes A, Wort SJ, Thomas H, Collinson P, Bennett ED: Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients. Crit Care 2006; 10:R60.
21. Ranson JH: Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982; 77: 633-638.
22. Bone RC, Sibbald WJ, Sprung CLT: The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101: 1481- 1483.
23. Lo YMD, Rainer TH, Chan LYS, Hjelm NM, Cocks RA: Plasma DNA as a prognostic marker in trauma patients. Clin Chem 2000;46: 319-323.
24. Rau BM, Kemppainen EA, Gumbs AA, Büchler MW, Wegscheider K, Bassi C, Pou-lakkainen PA, Beger HG: Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT). A prospective international multi-center study. Ann Surg 2007; 245: 745-754.
25. Balthazar EJ, Robinson DL, Megibow AJ: Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174: 331-336.
26. Yasuda T, Ueda T, Takeyama Y, Shinzeki M, Sawa H, Nakajima T, Ajiki T, Fujino Y, Suzuki Y, Kuroda Y: Significant increase of serum high-mobility group box chromosomal protein 1 levels in patients with severe acute pancreatitis. Pancreas 2006; 33: 359-363.
27. Sawa H, Ueda T, Takeyama Y, Yasuda T, Shinzeki M, Nakajima T, Kuroda Y: Blockade of high mobility group box-1 protein attenuates experimental severe acute pancreatitis. World J Gastroenterol 2006; 12: 7666-7670.
28. Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E: Involvement of toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem 2004; 279:7370- 7377.
29. Yamagishi S, Adachi H, Nakamura K, Mat-sui T, Jinnouchi Y, Takenaka K, Takeuchi M, Enomoto M, Furuki K, Hino A, Shigeto Y, Imaizumi T: Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabet-ic subjects. Metabolism 2006; 55: 1227-1231.
30. Basta G, Sironi AM, Lazzerini G, Del Turco S, Buzzigoli E, Casolaro A, Natali A, Ferran-nini E, Gastaldelli A: Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein. J Clin Endocrinol Metab 2006; 91: 4628-4634.
31. Bagul A, Pushpakom S, Boylan J, Newmann W, Siriwardena AK: Quantitative analysis of plasma DNA in severe acute pancreatitis. J Pancreas 2006; 7:602-607.
32. Hahn S, Zhong XY, Holzgreve W: Quantification of circulating DNA: in the preparation lies the rub. Clin Chem 2001; 47: 1577- 1578.